We serve Chemical Name:2-(Chloromethyl)biphenyl CAS:38580-83-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Chloromethyl)biphenyl
CAS.NO:38580-83-5
Synonyms:2-(Chloromethyl)biphenyl;1,1′-Biphenyl, 2-(chloromethyl)-;1-(chloromethyl)-2-phenylbenzene
Molecular Formula:C13H11Cl
Molecular Weight:202.679
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:334.0±21.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.579
PSA:
Exact Mass:202.054932
LogP:4.24
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(Chloromethyl)biphenyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(chloromethyl)-2-phenylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′-Biphenyl, 2-(chloromethyl)- Use and application,1-(chloromethyl)-2-phenylbenzene technical grade,usp/ep/jp grade.
Related News: Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 2-(Chloromethyl)biphenyl manufacturer Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 2-(Chloromethyl)biphenyl supplier API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 2-(Chloromethyl)biphenyl vendor Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 2-(Chloromethyl)biphenyl factory Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.